Company:  NEVRO CORP (NVRO)
Form Type:  4
Filing Date:  9/13/2017 
CIK:  0001444380 
Address:  1800 BRIDGE PARKWAY 
City, State, Zip:  REDWOOD CITY, California 94065 
Telephone:  650-251-0005 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$80.71  
Change: 
1.94 (2.46%)  
Trade Time: 
Nov 17  
Market Cap: 
$2.39B
Trade NVRO now with 

© 2017  
Description of Business
We are a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. We have developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Our proprietary paresthesia-free HF10 therapy, delivered by our Senza system, was demonstrated in our SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. Our SENZA-RCT study, along with our European studies, represents what we believe is the most robust body of clinical evidence for any SCS therapy.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES